The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description

Louise Paterson, Remy Flechais, Anna Murphy, Laurence Reed, Sanja Abbott, Venkataramana Boyapati, Rebecca Elliott, David Erritzoe, Karen D. Ersche, Yetunde Faluyi, Luca Faravelli, Emilio Fernandez-Egea, Nicola J. Kalk, Shankar Kuchibatla, John McGonigle, Antonio Metastasio, Inge Mick, Liam J. Nestor, Csaba Orban, Filippo PassettiEugenii A. Rabiner, Dana Smith, John Suckling, Roger Tait, Eleanor Taylor, Adam D. Waldman, Trevor W. Robbins, J. F. William Deakin, David J. Nutt, Anne Lingford-Hughes

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description'. Together they form a unique fingerprint.

Medicine & Life Sciences